CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
CollPlant Biotechnologies Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026
$3.56−0.06 (-1.79%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$19.64 (−84.66%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
CollPlant Biotechnologies Ltd grew revenue 360.4% to $2.37M over fiscal 2025. Free cash flow was -$9.45M.
Revenue
$2.37M
+360.4% vs. a year earlier
Operating income
-$11.48M
FY2025
Free cash flow
-$9.45M
FY2025
EPS, diluted
-$0.94
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $2.37M
- Net income
- -$11.49M
- EPS, diluted
- -$0.94
- Free cash flow
- -$9.45M
Eleven years at a glance
Fiscal years 2015 to 2025, USD
Revenue
$2.37M+360.4% YoY
Gross profit
$1.54M
Operating income
-$11.48M
Net income
-$11.49M
EPS, diluted
-$0.94
Free cash flow
-$9.45M
Reported period